All
Media
How I use AI to turn failed drugs into new medicines
All
Blog
Will the “SaaSpocalypse” come for drug discovery?
All
Media
Ignota buys Kronos' pipeline, igniting 2nd chance salvo to rescue shelved programs
All
Press release
Ignota Labs Acquires Kronos’s Clinical Pipeline
Latest news
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
All
Blog
What the ART preprint tells us about agents that read primary data
All
Research
Divergent Mechanisms of Gefitinib Hepatotoxicity in Metabolically and Genetically Diverse Hepatocyte Models
All
Media
AI is transforming science. How do we ensure accountability?
All
Press release
Ignota Labs Establishes Scientific Advisory Board
All
Research
Multimodal cheminformatic and network biology analysis enables deeper mechanistic understanding of PFAS-induced hepatotoxicity
All
Media
How I use AI to turn failed drugs into new medicines
All
Blog
Monarchy and Democracy: A History of Leadership
All
Blog
Will the “SaaSpocalypse” come for drug discovery?
All
Event
Highly Commended for AI Company of the Year award
.webp)
All
Research
Ignota Labs named among 10 winners of AI for Science Datasets RFP
All
Blog
Speed to candidate vs clinical translation
All
Press release
Jordan Lane appointed as a member of the UK Young Academy
All
Media
18 UK biotech startups you’ll want on your radar in 2026
All
Blog
Good metrics won’t save lives
All
Blog
Long-term safety: The hardest challenge facing longevity medicine
All
Media
SYK inhibitors market, drug price, sales & clinical trials outlook 2030
All
Media
Old drug, new tricks: AI helps rescue failed medicines
All
Blog
The cost of lost knowledge in drug development
All
Media
BBC Persian Click interviews Layla Hosseini-Gerami
All
Media
Capital injection
All
Media
Can abandoned drugs still save lives?
All
Event
Layla Hosseini-Gerami wins Women of the Future Science Award
All
Blog
If you want to change the world, you must first understand it
All
Media
How AI can reshape the pharma and R&D funnel
All
Event
Reviving drugs: the ultimate goal in drug discovery sustainability?
All
Blog
The right drug, wrong patients
.2.jpg)
All
Event
Media
Aylesbury High School honours former pupil Dr Layla Hosseini-Gerami.
All
Event
Rethinking Platform Biotech - How Emerging Innovators Are Structuring the Future of Pharma Collaboration
All
Media
Ignota buys Kronos' pipeline, igniting 2nd chance salvo to rescue shelved programs
All
Press release
Ignota Labs Acquires Kronos’s Clinical Pipeline
All
Event
Predicting human biology in the era of foundational models
All
Blog
Discovery is not the issue
All
Event
Ignota Labs sponsors Next Tech Fest 2025
All
Press release
2025 Cross-Sector Experience Awards announced
All
Event
Best Practices for Applying AI in Small Molecule Toxicology
All
Media
Fixing failed drugs - AI solutions for toxicity in drug discovery Part 3
All
Media
Ignota Labs CSO Jordan Lane becomes an enterprise fellow at Clare Hall
All
Media
Fixing failed drugs - AI solutions for toxicity in drug discovery Part 2
All
Media
Fixing failed drugs - AI solutions for toxicity in drug discovery Part 1
All
Press release
Dr Jordan Lane appointed as Industry and Enterprise Fellow at Clare Hall, University of Cambridge
All
Media
Honour for CSO maintains upward trajectory for Ignota Labs
All
Event
Generative AI for Drug Discovery
All
Media
Turning failing drugs into hope for patients
All
Event
Biotech’s AI-Q: Smarter Strategies for Success
All
Media
Giving Drugs a Second Chance with AI
All
Research
Machine Learning for Toxicity Prediction Using Chemical Structures: Pillars for Success in the Real World
All
Event
From failures to first-in-class: Using AI to rescue and reposition assets
All
Media
Start-up of the Week
All
Media
Flipping Drugs - From PhD to CDSO
All
Media
Dr. Layla Hosseini-Gerami named to Forbes 30 under 30
All
Media
Alumni Stories and Successes: An Experimental Spirit
All
Event
AI For Drug Discovery & Development
All
Media
This startup is using AI to give failed drugs a second chance
All
Media
How biotechs are using AI to rescue failed drugs
All
Media
IWD 2025: TFN spotlights on 12 women reshaping the future of tech in Europe
All
Media
Who or what called you to lead?
All
Press release
Ignota Labs Raises USD $6.9M Seed Funding to Turn Around Failed Drugs
All
Event
Dr Layla Hosseini-Gerami invited to 10 Downing Street
All
Press release
Dr Layla Hosseini-Gerami named as one of Innovate UK’s trailblazing women innovators to watch in 2025
All
Press release
Ignota Labs secures Sanofi’s prestigious iDEA-Tech Award
All
Research
Advancing predictive toxicology: overcoming hurdles and shaping the future
All
Media
An interview with our CEO Sam Windsor
All
Press release
Ignota Labs In-Licenses First Proprietary Asset: Pioneering PDE9A Inhibitor Set to Transform Multi-Action Therapeutics
All
Media
Why drugs fail
All
Media
Rescuing failed drug projects
All
Press release
Ignota Labs accepted for the 2024 cohort of TechBio Boost
All
Research
Improved Detection of Drug-Induced Liver Injury
All
Press release
Ignota Labs winners at Royal Society of Chemistry’s Emerging Technologies Competition 2024
All
Press release
Ignota Labs named Milner Therapeutics Institute affiliated company
All
Media
Jordan Lane
All
Press release
OBN Awards Nomination
All
Media
A day in the life of a Chief Science Officer and Cofounder of Ignota Labs
All
Media
Using Explainable AI To Ensure Drug Discovery Safety
All
Media
Drug Discovery: Breaking Barriers
All
Press release
Ignota Labs named winners of ELRIG 2024 Research & Innovation Award
All
20 Pharma Startups to Watch in 2025
All
Press release
Ignota Labs appoints Didier Landais as Non-Executive Director
All
Research
The First Public Classifiers for FDA Drug-Induced Cardiotoxicity Rank
All
Press release
Safety first for Ignota Labs as it relocates AI-Pharma proposition to new Cambridge HQ
All
Media
Introducing Ignota Labs with cofounder Dr Layla Hosseini-Gerami
All
Media
11 drug discovery startups to watch, according to VCs
All
Blog
Why ChatGPT and the like will never gain acceptance in drug discovery
All
Blog